4Kristof AS,Magder S. Low systemic vascular resistance state in patients undergoing cardiopulmonary bypass. Cri Carc Med, 1999,27:1121-1127.
5Argenziano M,Choudri AF, Moazami N, et al. Vasodilatory hypotension after cardiopulmonary bypass: risk factors and potential mechanisms. Circulation, 1997,96:3805A.
6Mekontso Dessap A, Houel R, Soustelle C, et al. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg, 2001,71 : 1428-1432.
7Argenziano M, Chen JM, Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agenl. J Thorac Cardiovasc Surg, 1998,116 : 973-980.
8Krishnaswamy P, l.ubien E, Cloplon P, et al. Utility of H natriuretic peptide levels in identifying patients with left ventricular syslolic or diastolic dysfunction. Am J Med,2001,111:274-279.
10Brunner-La Roeca HP, Kaye DM, Woods Rl.,et al. Effects of intravenous brain natriurctic peptide on regional sympathetic activity in patients with chronic heart failure as corn pared with healthy control subjects. J Am Coll Cardiol, 2001,37: 1221-1227.
